$42.17
0.441.05%
At close: -
$42.17
0.000.00%
After Hours: 1:00 PM EDT
Mirum Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Mirum Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-12 | $-0.30 | $-0.45 | 33.3 % |
Jun 2024 | 2024-08-07 | $-0.52 | $-0.47 | -10.6 % |
Mar 2024 | 2024-05-08 | $-0.54 | $-0.48 | -12.5 % |
Dec 2023 | 2024-02-28 | $-0.66 | $-0.24 | -175.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-12 | $90.38M | $82.01M | 10.2 % |
Jun 2024 | 2024-08-07 | $77.88M | $75.25M | 3.49 % |
Mar 2024 | 2024-05-08 | $69.22M | $70.17M | -1.35 % |
Dec 2023 | 2024-02-28 | $69.55M | $67.76M | 2.65 % |
Mirum Pharmaceuticals (MIRM) is scheduled to report earnings on February 26, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.30, which beat the estimate of $-0.45.
The Actual Revenue was $90.4M, which beat the estimate of $82M.
Browse earnings estimates, EPS, and revenue on all stocks.